Emergent BioSolutions Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
EBS on NYSE
Industry
Pharmaceutical Preparations
Location
300 Professional Dr, Gaithersburg, Maryland

Insiders trading volume in the past year

Emergent BioSolutions Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fuad El-Hibri Director $2.44M Dec 3, 2021
Jennifer Lynne Fox EVP, Ext Aff, GC, Corp Sec $1.52M Jul 11, 2024
Coleen Glessner EVP, Quality & Ethics, and CPL $1.01M Jun 8, 2024
Richard S. Lindahl EVP, Chief Financial Officer $966K Jun 8, 2024
Robert Kramer President and CEO, Director $921K Jun 9, 2023
Donald W. DeGolyer Director $787K May 23, 2024
Neal Franklin Fowler Director $787K May 23, 2024
Louis W. Sullivan Director $605K May 23, 2024
Zsolt Harsanyi Chairman, Director $516K May 23, 2024
Ronald Richard Director $411K May 23, 2024
Marvin L. White Director $395K May 23, 2024
William Hartzel SVP, Bioservices $391K Jul 11, 2024
Sujata Tyagi Dayal Director $365K May 23, 2024
Keith Katkin Director $346K May 23, 2024
Kathryn C. Zoon Director $333K -$75.8K -18.6% Jun 4, 2024
Adam Havey EVP, Business Operations $317K Jun 9, 2023
Paul Anthony Williams SVP, Products Business $198K Jul 8, 2024
Atul Saran EVP, Chief Strat & Dev Officer $158K Feb 28, 2023
Katherine Strei EVP, Chief HR Officer $114K Feb 28, 2023
Jerome M. Hauer Director $105K May 25, 2023
George A. Joulwan Director $73.2K May 26, 2022
Karen L. Smith EVP, Chief Medical Officer $21.6K May 7, 2021
Joseph C. Papa President and CEO, Director $0 Mar 13, 2024
H. Haywood Miller III Interim CEO Jun 24, 2023

Recent Insider Transactions by Companies or Individuals for Emergent BioSolutions Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.